OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
July 06, 2016
Bio/pharma companies that are qualifying potential contract service providers should investigate post-merger integration activities and capital structure as part of the due diligence.
July 02, 2016
CDMOs need to be aware that unfavorable public markets put emerging bio/pharma R&D spending at risk in 2017.
CPhI Pharma Awards seek nominations for excellence in development and manufacturing.
Data integrity and cGMP issues demand closer scrutiny of suppliers. Bribery and corruption may become the next supply chain flashpoint.
July 01, 2016
The company expanded its services to include oligonucleotide API development and manufacturing and received approval for its Caponago manufacturing facility.
A RoTab tablet press can product up to 42,000 tablets per hour for Juniper Pharma Services.
Recipharm adds hardware, software, and cloud services for serialization compliance processes.
June 10, 2016
Brammer Bio establishes late-phase development and commercial manufacturing facility for advanced cell and gene therapies in Lexington, MA.
June 07, 2016
The new company is the product of a merger with Formex.
Uncertainty about the demand for a biologic medication can be partly mollified with some well-planned capacity outsourcing, contends a new report by ORC International sponsored by Patheon.